Beverley E Patterson

A geometrical approach to the PKPD modelling of inhaled bronchodilators

S. Panunzi, A. Gaetano, G. Cremona, 2012, Journal of Pharmacokinetics and Pharmacodynamics.

Effects of gender, age, diabetes mellitus and renal and hepatic impairment on tadalafil pharmacokinetics.

M. Mitchell, R. Wrishko, A. Bedding, 2007, British journal of clinical pharmacology.

Role of pharmacokinetics in establishing bioequivalence for orally inhaled drug products: workshop summary report.

A. Fuglsang, S. Lee, H. Derendorf, 2011, Journal of aerosol medicine and pulmonary drug delivery.

Pharmacokinetics (PK) of single doses of mometasone furoate (MF) delivered via the Breezhaler® (BH) and Twisthaler® (TH) devices in healthy subjects

Thomas M. Smith, Baldur P Magnusson, U. Malmqvist, 2012 .

Tadalafil pharmacokinetics in healthy subjects.

M. Mitchell, R. Wrishko, A. Bedding, 2006, British journal of clinical pharmacology.

A geometrical approach to the PKPD modelling of inhaled bronchodilators

S. Panunzi, A. Gaetano, G. Cremona, 2012, Journal of Pharmacokinetics and Pharmacodynamics.

IVIVC using in silico and PBPK methods for inhaled drug product development

V. Lukacova, W. Woltosz, Beverley E Patterson, 2017 .

Effect of Tadalafil on Cytochrome P450 3A4–mediated Clearance: Studies in Vitro and in Vivo

J. Gillespie, B. Ring, S. Wrighton, 2005, Clinical pharmacology and therapeutics.